Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Jul;61(7):1125-36.
doi: 10.1007/s00262-011-1187-z. Epub 2011 Dec 24.

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

Katayoun Rezvani  1 , Agnes S M Yong, Stephan Mielke, Bipin N Savani, Behnam Jafarpour, Rhoda Eniafe, Robert Quan Le, Laura Musse, Carole Boss, Richard Childs, A John Barrett
Affiliations
Clinical Trial

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

Katayoun Rezvani et al. Cancer Immunol Immunother. 2012 Jul.

Abstract

PR1, an HLA-A*0201 epitope shared by proteinase-3 (PR3) and elastase (ELA2) proteins, is expressed in normal neutrophils and overexpressed in myeloid leukemias. PR1-specific T cells have been linked to graft-versus-leukemia (GVL) effect. We hypothesized that lymphopenia induced by chemo-radiotherapy can enhance weak autoimmune responses to self-antigens such as PR1. We measured PR1-specific responses in 27 patients 30-120 days following allogeneic stem cell transplant (SCT) and correlated these with ELA2 and PR3 expression and minimal residual disease (MRD). Post-SCT 10/13 CML, 6/9 ALL, and 4/5 solid tumor patients had PR1 responses correlating with PR3 and ELA2 expression. At day 180 post-SCT, 8/8 CML patients with PR1 responses were BCR-ABL-negative compared with 2/5 BCR-ABL-positive patients (P = 0.025). In contrast, PR1 responses were detected in 2/4 MRD-negative compared with 4/5 MRD-positive ALL patients (P = 0.76). To assess whether the lymphopenic milieu also exaggerates weak T-cell responses in the autologous setting, we measured spontaneous induction of PR1 responses in 3 AML patients vaccinated with WT1-126 peptide following lymphodepletion. In addition to WT1-specific T cells, we detected PR1-specific T cells in 2 patients during hematopoietic recovery. Our findings suggest that lymphopenia induced by chemo-radiotherapy enhances weak autoimmune responses to self-antigens, which may result in GVL if the leukemia expresses the relevant self-antigen.

Trial registration: ClinicalTrials.gov NCT00433745.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CD8+ T-cell responses to PR1 in patients with CML, ALL, and solid tumor after SCT. a Comparison of frequencies of PR1/HLA-A*0201+ CD8+ T cells in patients with CML, ALL, and solid tumor after SCT. The values represent the PR1/HLA-A*0201+ CD8+ T-cell response for each patient at specific time points after SCT. Bars represent means. b Frequencies of PR1-specific CD8+ T cells by tetramer analysis (black bar) and PR1-specific IFN-γ-producing CD8+ T cells (gray bar)
Fig. 2
Fig. 2
PR3 and ELA2 gene expression in the peripheral blood of patients with CML, ALL, and solid tumor after SCT. a Correlation between PR3 and ELA2 expression in PB samples from the patients with CML, ALL, and solid tumor. b ELA2 gene expression in peripheral blood samples from the patients with CML, ALL, and solid tumor after SCT. Bars represent medians. Values of genes represent the RQ-PCR expression as a ratio of the gene of interest to the ABL control gene
Fig. 3
Fig. 3
PR1-specific CD8+ T-cell responses in peripheral blood in relation to ELA2 gene expression and absolute neutrophil count (ANC). Results in 6 individual patients are shown. The number of days after transplantation is shown on the x-axis. PR1/HLA-A*0201+ CD8+ T cells are expressed as absolute numbers/mL of peripheral blood (left, y-axis; light blue); the shaded area represents absolute numbers of CMVpp65495/HLA-A*0201+ CD8+ T cells. ELA2 gene expression in peripheral blood is expressed as the ratio of ELA2 to ABL (right, y-axis; dark blue). The ANC × 109/L are represented at each time point (gray line)
Fig. 4
Fig. 4
Quality of PR1-specific CD8+ T-cell response and GVL. a Avidity of PR1-specific CD8+ T cells was compared for patients with CML and ALL. Stimulation of PBMC with 0.1 and 10 μM of PR1 determined high- and low-avidity responses. Results show ratios of high- to low-avidity PR1 CD8+ T-cell responses in CML and ALL patients. Ratios were obtained by the following calculation: IFN-γ+ CD8+ T-cell (%) with 0.1 μM peptide/IFN-γ+ CD8+ T-cell (%) with 10 μM peptide. A ratio >1.0 represents predominantly high-avidity responses, whereas a ratio of <1.0 represents predominantly low-avidity responses. b Relationship between IFN-γ+ PR1-specific CD8+ T-cell responses and MRD at day +180 post-SCT, as assessed by BCR-ABL expression in CML and WT1 expression in ALL. Bars represent median values
Fig. 5
Fig. 5
PR1-specific CD8+ T-cell responses in patients vaccinated with WT1 peptide only following lymphodepletion. PR1-specific CD8+ T-cell responses (light blue line) are correlated with ELA-2/PR3 expression (dark blue line) and compared with WT1 vaccine-induced CD8+ T cells (red line)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol. 2007;19:318–330. doi: 10.1016/j.smim.2007.10.004. - DOI - PMC - PubMed
    1. Goldrath AW, Bevan MJ. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity. 1999;11:183–190. doi: 10.1016/S1074-7613(00)80093-X. - DOI - PMC - PubMed
    1. Clarke SR, Rudensky AY. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes. J Immunol. 2000;165:2458–2464. - PubMed
    1. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med. 2000;192:549–556. doi: 10.1084/jem.192.4.549. - DOI - PMC - PubMed
    1. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609–4616. - PubMed

Publication types

MeSH terms

Associated data